Cyprotex: Contact us to learn more about our full range of ADME, PK and toxicity services for the pharmaceutical, cosmetics, personal care and chemical industries - high quality robust data
Social Links
What is Cyprotex's Revenue?
Cyprotex's estimated revenue for 2024 is $15.7M.
What does Cyprotex do?
Cyprotex is the world's largest contract research organisation specialising in preclinical ADME Tox. Cyprotex provides the most complete range of ADME Tox CRO services available anywhere:
* High Throughput ADME screening
* Customised ADME assays
* In silico ADME predictive modeling
* In vitro toxicology
Sorry we could not load this information
You May Also Find These Company Reviews Interesting